Biotech · Private company
IntraBio Inc
Track this companyFree. Adds IntraBio Inc to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- N-Acetyl-L-LeucinePhase 3 · Ataxia-TelangiectasiaClinicalTrials.gov · fetched Nov 12, 2026
- N-Acetyl-L-LeucinePhase 3 · CACNA1AClinicalTrials.gov · fetched Nov 12, 2026
- N-Acetyl-L-LeucinePhase 3 · Niemann-Pick Disease, Type CClinicalTrials.gov · fetched Nov 12, 2026
- IB1001Phase 2 · Ataxia TelangiectasiaClinicalTrials.gov · fetched Nov 12, 2026
- IB1001Phase 2 · GM2 GangliosidosisClinicalTrials.gov · fetched Nov 12, 2026
- IB1001Phase 2 · Niemann-Pick Disease, Type CClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Pivotal Study of N-acetyl-L-leucine for CACNA1APHASE3 · ACTIVE_NOT_RECRUITING · started Aug 17, 2026ClinicalTrials.gov NCT07221292 · fetched Nov 12, 2026
- A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)PHASE3 · ACTIVE_NOT_RECRUITING · started Mar 18, 2025ClinicalTrials.gov NCT06673056 · fetched Nov 12, 2026
- A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type CPHASE3 · RECRUITING · started Jun 30, 2022ClinicalTrials.gov NCT05163288 · fetched Nov 12, 2026
- N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)PHASE2 · TERMINATED · started Jan 8, 2020ClinicalTrials.gov NCT03759678 · fetched Nov 12, 2026
- N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)PHASE2 · COMPLETED · started Sep 4, 2019ClinicalTrials.gov NCT03759639 · fetched Nov 12, 2026
- N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)PHASE2 · COMPLETED · started Jun 7, 2019ClinicalTrials.gov NCT03759665 · fetched Nov 12, 2026